Cargando…
Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis
BACKGROUND: Babies born preterm are at an increased risk of dying in the first weeks of life, and those who survive have a higher rate of cerebral palsy (CP) compared with babies born at term. The aim of this individual participant data (IPD) meta-analysis (MA) was to assess the effects of antenatal...
Autores principales: | Crowther, Caroline A., Middleton, Philippa F., Voysey, Merryn, Askie, Lisa, Duley, Lelia, Pryde, Peter G., Marret, Stéphane, Doyle, Lex W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627896/ https://www.ncbi.nlm.nih.gov/pubmed/28976987 http://dx.doi.org/10.1371/journal.pmed.1002398 |
Ejemplares similares
-
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
por: Chollat, Clément, et al.
Publicado: (2017) -
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework
por: Bain, Emily, et al.
Publicado: (2015) -
Antenatal magnesium sulphate and adverse neonatal outcomes: A
systematic review and meta-analysis
por: Shepherd, Emily, et al.
Publicado: (2019) -
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
por: Bain, Emily S, et al.
Publicado: (2013) -
Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol
por: Crowther, Caroline A, et al.
Publicado: (2013)